Clinical trial
Contribution of Plasma Assays of Biomarkers of Muscle Metabolism During Exercise to the Assessment of Insulin Resistance in Chronic Renal Failure Patients Undergoing Hemodialysis.
NCT06360302 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Contribution of Plasma Assays of Biomarkers of Muscle Metabolism During Exercise to the Assessment of Insulin Resistance in Chronic Renal Failure Patients Undergoing Hemodialysis.
- Lead sponsor
- University Hospital, Montpellier
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- November 18, 2024
- Completion date
- November 18, 2026
- Enrollment
- 42 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
dialysis; complications, metabolic syndrome